Advertisement

Contemporary Management of Primary Hyperparathyroidism

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yeh M.W.
        • Ituarte P.H.
        • Zhou H.C.
        • et al.
        Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.
        J Clin Endocrinol Metab. 2013; 98: 1122-1129
        • Fisher S.B.
        • Perrier N.D.
        Primary hyperparathyroidism and hypertension.
        Gland Surg. 2020; 9: 142-149
        • Lind L.
        • Ljunghall S.
        Pre-operative evaluation of risk factors for complications in patients with primary hyperparathyroidism.
        Eur J Clin Invest. 1995; 25: 955-958
        • Kalla A.
        • Krishnamoorthy P.
        • Gopalakrishnan A.
        • et al.
        Primary hyperparathyroidism predicts hypertension: results from the National Inpatient Sample.
        Int J Cardiol. 2017; 227: 335-337
        • Trombetti A.
        • Christ E.R.
        • Henzen C.
        • et al.
        Clinical presentation and management of patients with primary hyperparathyroidism of the swiss primary hyperparathyroidism cohort: a focus on neuro-behavioral and cognitive symptoms.
        J Endocrinol Invest. 2016; 39: 567-576
        • Udelsman R.
        Six hundred fifty-six consecutive explorations for primary hyperparathyroidism.
        Ann Surg. 2002; 235: 665-672
        • Walgenbach S.
        • Hommel G.
        • Junginger T.
        Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study.
        World J Surg. 2000; 24: 564-570
        • Allendorf J.
        • DiGorgi M.
        • Spanknebel K.
        • et al.
        1112 Consecutive Bilateral Neck Explorations for Primary Hyperparathyroidism.
        World J Surg. 2007; 31: 2075-2080
        • Barczynski M.
        • Bränström G. Dionigi
        • Mihai R.
        Sporadic multiple parathyroid gland disease—a consensus report of the European Society of Endocrine Surgeons (ESES).
        Langenbeck’s Arch Surg. 2015; 400: 887-905
        • Low R.A.
        • Katz A.D.
        Parathyroidectomy via bilateral cervical exploration: a retrospective review of 866 cases.
        Head Neck. 1998; 20: 583-587
        • Lee Janet Y.
        • Shoback Dolores M.
        Familial hypocalciuric hypercalcemia and related disorders.
        Best Pract Res Clin Endocrinol Metab. 2018; 32: 609-619https://doi.org/10.1016/j.beem.2018.05.004
        • Kiriakopoulos A.
        • Petralias A.
        • Linos D.
        Classic primary hyperparathyroidism versus normocalcemic and normohormonal variants: do they really differ?.
        World J Surg. 2018; 42: 992-997
        • Applewhite Megan K.
        • White Michael G.
        • Tseng Jennifer
        • et al.
        Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism.
        Surgery. 2017; 161: 62-69
        • Mischis-Troussard C.
        • Goudet P.
        • Verges B.
        • et al.
        Primary hyperparathyroidism with normal serum intact parathyroid hormone levels.
        QJM: An Int J Med. 2000; 93: 365-367
        • Wallace Lucy B.
        • Parikh Rikesh T.
        • Ross Louis V.
        • et al.
        The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: How low can parathyroid hormone go?.
        Surgery. 2011; 150: 1102-1112
        • Khan A.A.
        • Hanley D.A.
        • Rizzoli R.
        • et al.
        Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.
        Osteoporos Int. 2017; : 1-19
        • Silverberg S.J.
        • Clarke B.L.
        • Peacock M.
        • et al.
        Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
        J Clin Endocrinol Metab. 2014; 99 (Summarizes data on the various traditional and nontraditional manifestations of PHPT according to the expert panel consensus of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. This report provides information on the natural history of PHPT, geographic differences of predominant phenotypes and various organ system involvement of PHPT): 3580-3594
        • Rubin M.R.
        • Bilezikian J.P.
        • McMahon D.J.
        • et al.
        The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.
        J Clin Endocrinol Metab. 2008; 93: 3462-3470
        • Bentrem D.J.
        • Angelos P.
        • Talamonti M.S.
        • et al.
        Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism?.
        Thyroid. 2002; 12: 1109-1112
        • Gilat H.
        • Cohen M.
        • Feinmesser R.
        • et al.
        Minimally invasive procedure for resection of a parathyroid adenoma: the role of preoperative high-resolution ultrasonography.
        J Clin Ultrasound. 2005; 33: 283-287
        • Wojtczak B.
        • Syrycka J.
        • Kaliszewski K.
        • et al.
        Surgical implications of recent modalities for parathyroid imaging.
        Gland Surg. 2020; 9: S86-S94
        • Nafisi Moghadam R.
        • Amlelshahbaz A.P.
        • Namiranian N.
        • et al.
        Comparative diagnostic performance of ultrasonography and 99mTc-sestamibi scintigraphy for parathyroid adenoma in primary hyperparathyroidism; systematic review and meta- analysis.
        Asian Pac J Cancer Prev. 2017; 18: 3195-3200
        • Rodgers S.E.
        • Hunter G.J.
        • Hamberg L.M.
        • et al.
        Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography.
        Surgery. 2006; 140 ([discussion: 940-1]): 932-940
        • Eichhorn-Wharry L.I.
        • Carlin A.M.
        • Talpos G.B.
        Mild hypercalcemia: an indication to select 4-dimensional computed tomography scan for preoperative localization of parathyroid adenomas.
        Am J Surg. 2011; 201 ([discussion: 338]): 334-338
        • Argirò R.
        • Diacinti D.
        • Sacconi B.
        • et al.
        Diagnostic accuracy of 3T magnetic resonance imaging in the preoperative localisation of parathyroid adenomas: comparison with ultrasound and 99mTc-sestamibi scans.
        Eur Radiol. 2018; 28: 4900-4908
        • Neumann D.R.
        • Obuchowski N.A.
        • Difilippo F.P.
        Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
        J Nucl Med. 2008; 49: 2012-2017
        • Beheshti M.
        • Hehenwarter L.
        • Paymani Z.
        • et al.
        18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.
        Eur J Nucl Med Mol Imaging. 2018; 45: 1762-1771
        • Solorzano C.C.
        • Carneiro-Pla D.
        Minimizing cost and maximizing success in the preoperative localization strategy for primary hyperparathyroidism.
        Surg Clin North Am. 2014; 94: 587-605
        • Mandl F.
        Klinisches und experimentelles zur frage der lokalisierten und generalisierten ostitis fibrosa: unter besonderer berücksichtigung der therapie der letzteren. Teil 2.
        Arch Klin Chir. 1926; 143: 245-248
        • Wang C.A.
        The anatomic basis of parathyroid surgey.
        Ann Surg. 1976; 183: 271-275
        • Mendoza V.
        • Ramirez C.
        • Espinoza A.E.
        • et al.
        Characteristics of ectopic parathyroid glands in 145 cases of primary hyperparathyroidism.
        Endocr Pract. 2010; 16: 977-981
        • Phitayakorn R.
        • McHenry C.R.
        Incidence and location of ectopic abnormal parathyroid glands.
        Am J Surg. 2006; 191: 418-423
        • van Heerden J.A.
        • Grant C.S.
        Surgical treatment of primary hyperparathyroidism: an institutional perspective.
        World J Surg. 1991; 15: 688-692
        • Martinez D.A.
        • King D.R.
        • Romshe C.
        • et al.
        Intraoperative identification of parathyroid gland pathology: a new approach.
        J Pediatr Surg. 1995; 30: 1306-1309
        • Norman J.
        • Chheda H.
        Minimally invasive parathyroidectomy facilitated by intraoperative Nucl mapping.
        Surgery. 1997; 122: 998-1003
        • Westerdahl J.
        • Bergenfelz A.
        Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone.
        World J Surg. 2004; 28: 1132-1138
        • Westra W.H.
        • Pritchett D.D.
        • Udelsman R.
        • et al.
        Intraoperative confirmation of parathyroid tissue during parathyroid exploration.
        Am J Surg Pathol. 1998; 22: 538-544
        • Satchie B.
        • Chen H.
        Radioguided techniques for parathyroid surgery.
        Asian J Surg. 2005; 28: 77-81
        • Murphy C.
        • Norman J.
        The 20% rule: A simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy.
        Am Assoc Endocr Surgeons. 1999; 126https://doi.org/10.1067/msy.2099.101578
        • McGreal G.
        • Winter D.C.
        • Sookhai S.
        • et al.
        Minimally invasive, radioguided surgery for primary hyperparathyroidism.
        Ann Surg Oncol. 2001; 8: 856-860
        • Angelos P.
        An initial experience with radioguided parathyroid surgery.
        Am J Surg. 2000; 180: 475-478
        • Takami H.
        • Takayama J.
        • Ikeda Y.
        • et al.
        Section 1. Parathyroid: minimally invasive radioguided parathyroidectomy.
        . 2002; 56: 37-40
        • Livingston C.D.
        Radioguided parathyroidectomy is successful in 98.7% of selected patients.
        Endocr Pract. 2014; 20: 305-309
        • Goldstein R.E.
        • Blevins L.
        • Delbeke D.
        • et al.
        Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism.
        Ann Surg. 2000; 231: 732-742
        • Irvin 3rd, G.L.
        • Dembrow V.D.
        • Prudhomme D.L.
        Operative monitoring of parathyroid gland hyperfunction.
        Am J Surg. 1991; 162: 299-302
        • Irvin 3rd, G.L.
        • Prudhomme D.L.
        • Deriso G.T.
        • et al.
        A new approach to parathyroidectomy.
        Ann Surg. 1994; 219: 574-579
        • Westerdahl J.
        • Lindblom P.
        • Bergenfelz A.
        Measurement of Intraoperative Parathyroid Hormone Predicts Long-term Operative Success.
        Arch Surg. 2002; 137: 186-190
        • Grant C.S.
        • Thompson G.
        • Farley D.
        • et al.
        Primary Hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: mayo clinic experience.
        Arch Surg. 2005; 140: 472-479
        • Irvin 3rd, G.L.
        • Carneiro D.M.
        • Solorzano C.C.
        Progress in the operative management of sporadic primary hyperparathyroidism over 34 years.
        Ann Surg. 2004; 239: 704-711
        • Chen Herbert
        • Sokoll Lori J.
        • Udelsman Robert
        Outpatient minimally invasive parathyroidectomy: A combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay.
        Surgery. 1999; 126: 1016-1022
        • Fahy B.N.
        • Bold R.J.
        • Beckett L.
        • et al.
        Modern parathyroid surgery: a cost-benefit analysis of localizing strategies.
        Arch Surg. 2002; 137: 917-922
        • Chiu B.
        • Sturgeon C.
        • Angelos P.
        Which intraoperative parathyroid hormone assay criterion best predict operative success? A study of 352 consecutive patients.
        Arch Surg. 2006; 141: 483-487
        • Barczynski M.
        Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring: When and why?.
        J Postgrad Med. 2009; 55: 239-240
        • Clerici T.
        • Brandle M.
        • Lange J.
        • et al.
        Impact on intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease.
        World J Surg. 2004; 28: 187-192
        • McGill J.
        • Sturgeon C.
        • Kaplan S.P.
        • et al.
        How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies.
        J Am Coll Surg. 2008; 207: 246-249
        • Stavrakis A.I.
        • Ituarte P.H.
        • Ko C.Y.
        • et al.
        Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery.
        Surgery. 2007; 142 ([discussion 887-99]): 887-899
        • Neychev V.K.
        • Ghanem M.
        • Blackwood S.L.
        • et al.
        Parathyroid surgery can be safely performed in a community hospital by experienced parathyroid surgeons: A retrospective cohort study.
        Int J Surg. 2016; 27: 72-76
        • Sosa J.A.
        • Bowman H.M.
        • Tielsch J.M.
        • et al.
        The importance of surgeon experience for clinical and economic outcomes from thyroidectomy.
        Ann Surg. 1998; 228: 320-330
        • Meltzer C.
        • Klau M.
        • Gurushanthaiah D.
        • et al.
        Surgeon Volume in parathyroid surgery—surgical efficiency, outcomes, and utilization.
        JAMA Otolaryngol Head Neck Surg. 2017; 143: 843-847
        • Adam M.A.
        • Roman S.A.
        • Sosa J.A.
        Outpatient parathyroidectomy.
        in: Stack Jr., B. Bodenner D. Medical and surgical treatment of parathyroid diseases. Springer, Cham (Switzerland)2017
        • Tuggle Charles T.
        • Roman Sanziana A.
        • Wang Tracy S.
        • et al.
        Pediatric endocrine surgery: Who is operating on our children?.
        Surgery. 2008; 144: 869-877
        • Erinjeri N.
        • Udelsman R.
        Volume-outcome relationship in parathyroid surgery.
        Best Pract Res Clin Endocrinol Metab. 2019; 33: 101287
        • Ghani U.
        • Assad S.
        • Assad S.
        Role of intraoperative nerve monitoring during parathyroidectomy to prevent recurrent laryngeal nerve injury.
        Cureus. 2016; 8: e880
        • Dionigi G.
        • Bacuzzi A.
        • Boni L.
        • et al.
        Visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy: what about the costs?.
        World J Surg. 2012; 36: 748-754
        • Taylor J.
        • Fraser W.
        • Banaszkiewiz P.
        • et al.
        Lateralization of parathyroid adenomas by intra-operative parathormone estimation.
        J R Coll Surg Edinb. 1996; 41: 174-177
        • Ito F.
        • Sippel R.
        • Lederman J.
        • et al.
        The utility of intra-operative bilateral venous sampling with rapid parathyroid hormone testing.
        Ann Surg. 2007; 245: 959-963
        • Spartalis E.
        • Ntokos G.
        • Georgiou K.
        • et al.
        Intraoperative indocyanine green (ICG) angiography for the identification of the parathyroid glands: current evidence and future perspectives.
        Vivo. 2020; 34: 23-32
        • Cetani F.
        • Saponaro F.
        • Marcocci C.
        Non-surgical management of primary hyperparathyroidism.
        Best Pract Res Clin Endocrinol Metab. 2018; 32: 821-835
        • Wei Y.
        • Peng L.
        • Li Y.
        • et al.
        Clinical Study on safety and efficacy of microwave ablation for primary hyperparathyroidism.
        Korean J Radiol. 2020; 21: 572-581